These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14759354)

  • 1. The African American antiplatelet stroke prevention study.
    Weinberger J
    Curr Cardiol Rep; 2004 Mar; 6(2):115. PubMed ID: 14759354
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of antiplatelet therapy for secondary stroke prevention.
    Malinina D; Zema C; Sander S; Serebruany V
    Expert Rev Pharmacoecon Outcomes Res; 2007 Aug; 7(4):357-63. PubMed ID: 20528418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet treatment in primary and secondary stroke prevention in women.
    Caso V; Santalucia P; Acciarresi M; Pezzella FR; Paciaroni M
    Eur J Intern Med; 2012 Oct; 23(7):580-5. PubMed ID: 22939800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.
    Kapil N; Datta YH; Alakbarova N; Bershad E; Selim M; Liebeskind DS; Bachour O; Rao GHR; Divani AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):301-318. PubMed ID: 27461564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in antiplatelet use prior to incident ischaemic stroke over 7 years in a UK centre and the association with stroke subtype.
    White JR; Bettencourt-Silva JH; Potter JF; Loke YK; Myint PK
    Age Ageing; 2013 Sep; 42(5):594-8. PubMed ID: 23832263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.
    Kwok CS; Shoamanesh A; Copley HC; Myint PK; Loke YK; Benavente OR
    Stroke; 2015 Apr; 46(4):1014-23. PubMed ID: 25721018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of antiplatelet treatment before and after ischemic stroke, and an analysis of factors associated with antiplatelet treatment, in the Qingdao area of China.
    Wang X; Wang P; Yu TF; Zhang M; DU ZQ; Xing CM
    Chin Med J (Engl); 2011 Dec; 124(24):4254-9. PubMed ID: 22340395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study.
    Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1334-43. PubMed ID: 23080224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin.
    Kim JT; Park MS; Choi KH; Cho KH; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko YC; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim DE; Ryu WS; Shin DI; Yeo MJ; Kim WJ; Lee J; Lee JS; Saver JL; Bae HJ
    Stroke; 2016 Jan; 47(1):128-34. PubMed ID: 26604247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
    Lutsep HL
    Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.